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ABSTRACT 
We previously demonstrated in pigs with acute liver failure (ALF) that albumin dialysis using the molecular adsorbents 
recirculating system (MARS) attenuated a rise in intracranial pressure (ICP). This was independent of changes in arterial 
ammonia, cerebral blood flow and inflammation, allowing alternative hypotheses to be tested. The aims of the present 
study were to determine whether changes in cerebral extracellular ammonia, lactate, glutamine, glutamate, and energy 
metabolites were associated with the beneficial effects of MARS on ICP. Three randomized groups [sham, ALF (induced 
by portacaval anastomosis and hepatic artery ligation), and ALF+MARS] were studied over a 6-hour period with a 4-hour 
MARS treatment given beginning 2 hours after devascularization. Using cerebral microdialysis, the ALF-induced 
increase in extracellular brain ammonia, lactate, and glutamate was significantly attenuated in the ALF+MARS group as 
well as the increases in extracellular lactate/pyruvate and lactate/glucose ratios. The percent change in extracellular brain 
ammonia correlated with the percent change in ICP (r
2
 = 0.511). Increases in brain lactate dehydrogenase activity and 
mitochondrial complex activity for complex IV were found in ALF compared with those in the sham, which was 
unaffected by MARS treatment. Brain oxygen consumption did not differ among the study groups. Conclusion: The 
observation that brain oxygen consumption and mitochondrial complex enzyme activity changed in parallel in both ALF- 
and MARS-treated animals indicates that the attenuation of increased extracellular brain ammonia (and extracellular brain 
glutamate) in the MARS-treated animals reduces energy demand and increases supply, resulting in attenuation of 
increased extracellular brain lactate. The mechanism of how MARS reduces extracellular brain ammonia requires further 
investigation. (HEPATOLOGY 2007.) 
Abbreviations 
MARS, molecular adsorbents recirculating system; ALF, acute liver failure; LDH, lactate dehydrogenase; ICP, 
intracranial pressure. 
INTRODUCTION 
Acute liver failure (ALF) is defined by the occurrence of hepatic encephalopathy (HE), which is characterized by an 
increase in intracranial pressure (ICP) that may lead to cerebral herniation, an important cause of death.
1
 Current 
hypotheses suggest that increased ICP in ALF is the result of multiple factors that involve the effects of 
hyperammonemia, increased cerebral blood flow, and inflammation.
2
 Increased brain ammonia, arising from the onset of 
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hyperammonemia, is detrimental to neurological function.
3
 Arterial ammonia levels, ammonia brain delivery, and 
metabolic rate correlate with severity of intracranial hypertension and risk of cerebral herniation.
1, 4, 5 
Alterations in brain energy metabolism have been hypothesized to be involved in the cerebral consequences of ALF 
because ammonia is known to inhibit the rate-limiting enzyme α-ketoglutarate dehydrogenase in the tricarboxylic acid 
cycle (TCA).
6
 This is supported by experiments demonstrating an increase in de novo synthesis of lactate
7, 8
 from 
glucose (using nuclear magnetic resonance spectroscopy) in the brains of rats with ALF. As a result, this would lead to 
less adenosine triphosphate (ATP) production per molecule of glucose compared with that in aerobic metabolic pathways 
(through TCA cycle). Therefore, increased ammonia in the brain reduces generation of ATP. On the other hand, elevated 
ammonia also increases energy demand. Ammonia detoxification through glutamine synthetase activity and stimulation 
of glutamate uptake by ammonia into astrocytes
9
 along with activation of NMDA receptors
10
 (both resulting in increased 
Na
+
-K
+
-adenosine triphosphatase [ATPase] activity) all require ATP. Thus, ammonia affects brain bioenergetics, through 
both an increase in the demand for and a reduction in the supply of ATP. 
Albumin dialysis, using the molecular adsorbents recirculating system (MARS), removes protein bound substances from 
the blood. Several controlled clinical trials have shown that MARS therapy is an effective treatment for HE.
11–16
 The 
mechanism by which MARS treatment results in improved HE is not clear, as results showing a reduction in blood 
ammonia with MARS have been inconsistent. In keeping with the results in humans, we recently showed attenuation in 
the rise in ICP (following a 4-hour MARS treatment) in a porcine model of ALF (induced by liver devascularization).
17
 
This beneficial effect of MARS was not associated with any significant changes in arterial ammonia, cerebral blood flow, 
or severity of inflammation,
17
 allowing the use of this model and MARS therapy as an experimental tool to explore 
alternative pathophysiological mechanisms that may be important in the pathogenesis of intracranial hypertension in 
ALF. The aims of the present study were to determine whether changes in ammonia, glutamine, glutamate, and energy 
metabolites in the extracellular compartment of the brain are associated with the changes in ICP previously observed in 
ALF- and ALF+MARS-treated pigs.
17
 
MATERIALS AND METHODS 
The study was performed in the Surgical Research Laboratory at the University of Tromsø, Norway, and was approved 
by the Norwegian Experimental Animal Board. Twenty-four female Norwegian Landrace pigs from 3 litters weighing 
23–30 kg (mean weight ± SEM: 26.8 ± 0.3 g) were used. 
Study Design. 
The pigs were randomized into 3 groups17: sham, ALF, and ALF+MARS (8 per group). ALF was induced by 
devascularization of the liver. This was achieved with an end-to-side portacaval anastomosis followed by hepatic artery 
ligation (HAL). In the sham group, a laparotomy was performed without interfering with hepatic blood supply. Details of 
the operation were described previously.
18, 19
 Time (T) = 0 was defined as following HAL in the ALF and ALF+MARS 
groups or just prior to closing the abdominal wall in the sham group. All pigs were monitored over 6 hours. In the 
ALF+MARS group, a 4-hour MARS dialysis treatment began at T = 2 hours. Experiments were terminated at T = 6 hours 
by giving the pigs an overdose of pentobarbital and potassium chloride. 
Animal Model. 
The animal room facilities, anesthesia, and surgical preparation have previously been described in detail.
12, 17–20
 The pigs 
were premedicated with an intramuscular injection of ketamine (20 mg/kg) and atropine (1 mg). To prevent any 
preoperative dehydration, all animals received 500 mL of 0.9% NaCl containing 625 mg of glucose. The pigs were 
anesthesized with an intravenous bolus of 10 mg/kg pentobarbital and 10 mg/kg fentanyl and were maintained during the 
operation with a central venous infusion of 4 mg pentobarbital/kg per hour, 0.02 mg fentanyl/kg per hour, and 0.3 mg 
midazolam/kg per hour. Anesthesia was terminated following HAL, and small bolus doses of fentanyl and midazolam 
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were given when clinical signs of light sedation appeared. Becuase of drug removal by MARS,12 animals were kept 
sedated with a continuous infusion of 0.04 mg fentanyl/kg per hour and 0.6 mg midazolam/kg per hour. 
The pigs were ventilated (PaCO2 4.5–5.0 kPa) throughout the experiment and infused with 0.9% NaCl, 5% glucose, and 
20% human albumin (to counteract intra-abdominal proteinaceous fluid loss during and after surgery) as described 
previously.12, 17–20 Normal core body temperature was maintained at 38.5°C ± 1°C. Heparin was used to keep the 
activated clotting time (ACT) > 100 seconds (>180 seconds during MARS). 
Catheter Placement. 
A very thin catheter
21
 was introduced into the abdominal aortas of the pigs in all 3 groups. MARS was performed through 
an 11.5Fr dual-lumen catheter (Mahurkar, Tyco Healthcare, UK) in the inferior vena cava. To be comparable, ALF and 
sham animals also received a vena caval catheter. 
MARS. 
MARS (Monitor 1, Teraklin AG, Rostock, Germany)
2, 22, 23
 works on the basis that blood is dialyzed across an albumin-
impregnated membrane with 20% human albumin in the dialysate. Albumin-bound toxins detach from the blood, bind to 
free-binding sites on the membrane, and then bind to the albumin in the dialysate. The dialysate is then activated through 
the charcoal and anion-exchanger (adsorbing albumin-bound toxins). The ―regenerated‖ albumin is then recirculated, 
allowing for removal of more toxins from the blood.
22, 23
 A roller pump (Stöckert Shiley, Munich, Germany) and the 
MARS pump perfusing the blood and albumin dialysate were running at the same rate (15 0 mL/minute). 
Microdialysis. 
A burr hole was created over the right frontal region of the skull (1 cm lateral, 2 cm rostral from bregma, and 0.5 cm 
ventral), the dura mater was incised, and a microdialysis catheter [CMA 70: 10-mm-long semipermeable membrane 
(20,000 Da cutoff) and an outer diameter of 0.6 mm] was placed into the cortex at least 1 hour before T = 0. The burr 
hole was sealed with bone wax to ensure stable positioning of the catheter and to prevent pressure release. The 
microdialysis catheter was connected to a microinjection pump (CMA/106 microinjection pump; CMA Microdialysis 
AB, Stockholm, Sweden) and perfused with artificial CSF (Na
+
 147 mmol/L; K
+
 4 mmol/L; Ca
2+
 2.3 mmol/L; Cl
−
 156 
mmol/L) at a flow rate of 2.0 μL/minute. The microdialysate was collected in microvials every hour, resulting in 120 μL 
for biochemical analysis. Samples were stored at −20°C. At the end of each experiment, a craniotomy was performed, and 
the brain was removed, dissected and examined for any intracranial hemorrhaging. 
Extracellular Brain Glucose, Glutamate, Lactate, and Pyruvate Measurements. 
The microdialysis samples were analyzed using a CMA 600 Microdialysis Analyzer (CMA Microdialysis AB). The 
analyzer measures glucose, lactate, pyruvate, and glutamate concentrations using small-volume samples. The 
methodologies are based on enzymatic oxidation and colorimetric measurements (CMA Microdialysis AB). 
Extracellular Brain Glutamine Measurement. 
Glutamine from microdialysis samples were measured and analyzed using a Perkin-Elmer reverse-phase HPLC system 
with fluorescence detection and precolumn o-phthalaldehyde derivatization.
24
 
Extracellular Brain Ammonia Measurement. 
Microdialysate ammonia level was determined using an ammonia reagent kit (Sigma-Aldrich, St. Louis, MO), which was 
used in conjunction with an automated enzymatic method (Cobas Fara II, Roche, Basel, Switzerland). 
Microdialysis Recovery Rates. 
Using the same microdialysis probes and microperfusion pump (at a flow rate of 2.0 μL/minute), we measured in vitro 
the recovery rate for each microdialysate analyte measured. This was done by immersing the probe in a solution of known 
concentrations of glucose, glutamate, glutamine, lactate, and pyruvate and measuring the concentrations of all 5 analytes 
in the collected microdialysate. The recovery rate at 2.0 μL/minute was 46.7% ± 7.1% for all analytes. 
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Arterial Lactate Measurement. 
Arterial blood was collected every 2 hours and centrifuged, and the plasma was stored at −70°C for subsequent analysis. 
Arterial plasma lactate level was determined using a lactate reagent kit (Sigma-Aldrich, St. Louis, MO) with an 
automated enzymatic method (Cobas Fara II, Roche, Basel, Switzerland). 
Lactate Dehydrogenase Activity. 
Following termination of experiments, the brain was rapidly removed, and samples were dissected from the frontal cortex 
and homogenized at 4°C in phosphate-buffered saline containing a protease inhibitor cocktail (Sigma-Aldrich, St. Louis, 
MO). Homogenates were vortexed, set on ice for 10 minutes, and then centrifuged at 10,000g for 5 minutes at 4°C. 
Lactate dehydrogenase (LDH) activity was assayed in supernatant within 24 hours, and samples were kept at 4°C at all 
times. Cell suspensions were mixed with NADH (0.13 mM; Sigma-Aldrich, St. Louis, MO) and concentrations of 
pyruvic acid (Sigma-Aldrich, St. Louis, MO) ranging from 0.01 to 1 mM in a 0.1M potassium phosphate buffer (pH = 
7.4). LDH activity was assessed over a 2-minute period by following the rate of oxidation of NADH as measured by 
spectrophotometric absorbance at 340 nm. 
Oxygen Consumption. 
Oxygen consumption was calculated from the blood gas measurements (Rapidab 800, Chiron Diagnostics, MD) in 
samples collected from catheters inserted into the carotid artery and a separate catheter inserted in the reverse direction 
with its tip in the jugular bulb. The sampling from this catheter represents the venous drainage from the brain. Extraction 
was calculated as a percentage using the formula [(CaO2 − CvO2)/CaO2] × 100. 
Mitochondrial Complex Activities. 
Mitochondrial complex activity was measured by well-described spectrophotometric methods (Agilent 8543 Diode array 
spectrophotometer, Agilent Technologies, UK).
25
 Tissue samples were homogenized on ice with a handheld glass 
homogenizer, then underwent 3 episodes of rapid freeze-thawing to ensure cell lysis. Complex activity was measured as 
the inhibitor sensitive rates (rotenone for complex I, antimycin A for complexes II and III, and cyanide for complex IV). 
To correct for mitochondrial enrichment in the sample, results are expressed as a ratio of citrate synthase activity.
26
 
Cytochrome c Oxidase. 
Cytochrome c oxidase concentration in the tissue homogenate was determined spectrophotometrically as the reduced 
cyanide complex. Briefly, a sample of homogenate was incubated in a phosphate buffer solution (100 mM, pH 7.1) 
containing sodium ascorbate (30mM), TMPD (0.15 mg/mL), and potassium cyanide (30 mM). After 2 minutes, 
absorbance was measured at 605 nm, and the concentration was calculated using an extinction coefficient of 24 
mM
−1
cm
−1
. 
Statistics. 
Results are expressed as mean ± SEM. Significance of differences within a group was tested by the paired Student t test, 
and the significance of differences between groups was measured by 1- or 2-way analysis of variance (ANOVA) where 
applicable. A difference with a P value < 0.05 was considered statistically significant. GraphPad Prism 4.0 (GraphPad 
Software, San Diego, CA) was used for statistical analyses. 
RESULTS 
As previously mentioned,17 3 pigs were excluded (1 sham and 1 ALF because of intracranial hemorrhage and 1 ALF 
because of technical problems with ICP monitoring), leaving a total of 21 pigs analyzed: 7 sham, 6 ALF, and 8 
ALF+MARS. 
Extracellular Brain Ammonia and Lactate. 
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Two hours following the onset of liver devascularization (pre-MARS treatment), a significant increase in extracellular 
brain ammonia was observed in pigs with ALF compared with sham-operated control pigs (Fig. 1A). Extracellular 
ammonia continued to rise in pigs with ALF, whereas this rise was attenuated at T = 6 hours following a 4-hour treatment 
with MARS (P < 0.01; Fig. 1A). Transforming the data into percent increase (from T = 0 in each group), an earlier 
attenuation with MARS was observed, as early as 2 hours following MARS treatment (at T = 4–6; Fig. 1B). To 
emphasize the effect of MARS on extracellular ammonia, the percent change in extracellular brain ammonia was 
calculated from T = 2 hours (start of the MARS treatment) until T = 6 hours (end of the MARS treatment), as shown in 
Fig. 1C. Using all 6 times from all 3 groups, a significant correlation was calculated between percent change in 
extracellular ammonia and percent change in ICP (r
2
 = 0.511, P < 0.001; Fig. 1D). 
 
Figure 1. (A) Extracellular brain concentrations of ammonia following induction of ALF (T = 0). (B) 
Percent increase [from baseline (T = 0)] of extracellular concentrations of ammonia. (C) Percent change 
(from T = 2–6) in extracellular ammonia. (D) Correlation between change in extracellular brain ammonia 
and change in ICP (***P < 0.001, **P < 0.01, *P < 0.05 versus SHAM; 
†††
P < 0.001, 
††
P < 0.01, ALF 
versus MARS; 1-way ANOVA). 
Extracellular concentrations of brain lactate in ALF demonstrated a similar pattern as that observed with extracellular 
brain ammonia, where extracellular brain lactate was significantly higher than shams at T = 2 (2 hours following liver 
devascularization; Fig. 2A). As early as 1 hour following MARS treatment, extracellular brain lactate normalized, which 
persisted until T = 6 hours. 
This is the peer reviewed version of the following article: Rose C, Davies NA, Ytrebø LM, Sen S, Nedredal GI, Belanger M, Revhaug 
A, Jalan R. Association of reduced extracellular brain ammonia, lactate, and intracranial pressure in pigs with acute liver failure. 
Hepatology 2007;46(6):1883–92. which has been published in final form at http://dx.doi.org/10.1002/hep.21877 
 
Figure 2. (A) Extracellular concentrations of lactate following induction of ALF (T = 0). (B) Correlation 
between extracellular brain ammonia and lactate (***P < 0.001, **P < 0.01 versus SHAM; 
††
P < 0.01, 
†
P 
< 0.05, ALF versus MARS; 2-way ANOVA). 
Using all 6 times from all 3 groups, a significant correlation was found between extracellular brain ammonia and 
extracellular brain lactate concentrations (r
2
 = 0.632, P < 0.001; Fig. 2B). No significant correlations were found between 
percent change in ICP and percent change in extracellular brain lactate (data not shown). 
Arterial Lactate. 
Arterial lactate concentrations were significantly increased in ALF and ALF+MARS at all times—2, 4, and 6 hours—
compared to in the sham pigs (Fig. 3). No significant differences were found between ALF and ALF+MARS at any time. 
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Figure 3. Arterial concentrations of lactate following induction of ALF at T = 0 (***P < 0.001, **P < 0.01, 
*P < 0.05 versus SHAM; 1-way ANOVA). 
Arterial and Extracellular Brain Glucose. 
Arterial glucose levels were closely monitored and controlled to remain within physiological concentrations in all 3 
groups (Table 1). No significant changes were found in extracellular brain glucose concentration in any of the 3 groups 
over the 6-hour duration of the experiment (Table 1). 
 
Extracellular Brain Pyruvate. 
No significant changes were measured in extracellular brain pyruvate in any of the 3 groups over the 6-hour duration of 
the experiment (Table 1). 
Ratios of Brain Energy Metabolites. 
Ratio of extracellular brain lactate/pyruvate, a measure of anaerobic metabolism,27 was found to be significantly 
increased at T = 6 hours in the ALF group compared with the sham group (P < 0.05; Fig. 4A). At the same time, a 4-hour 
MARS treatment attenuated this increase. 
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Figure 4. (A) Extracellular brain lactate/pyruvate ratio and (B) extracellular brain lactate/glucose ratio 
following induction of ALF at T = 0 (***P < 0.001, **P < 0.01, *P < 0.05, versus SHAM; 
†
P < 0.05, ALF 
versus MARS; 2-way ANOVA). 
A significant increase in the ratio of extracellular brain lactate/glucose (indicating accelerated glycolysis) was found in 
the ALF group versus the sham group at T = 5 hours (P < 0.01) and T = 6 hours (P < 0.001). A 4-hour treatment of 
MARS resulted in normalization at T = 6 hours (P < 0.05; Fig. 4B). 
Extracellular Brain Glutamate, Glutamine. 
Extracellular brain glutamate was significantly increased in the ALF group at T = 5 hours (P < 0.01) and T = 6 hours (P 
< 0.01) compared to the sham group and normalized at the same times with MARS following 3 hours (P < 0.05) and 4 
hours (P < 0.001) of treatment (Fig. 5A). Extracellular brain glutamine was significantly increased in the ALF group 
compared to the sham group at T = 3–6 hours (P < 0.05). MARS treatment had no effect on extracellular brain glutamine, 
as a significant increase was also found in the ALF+MARS group compared to the sham group, however, only from T = 
4 to 6 hours (P < 0.01; Fig. 6B). No significant correlations were found between percent change in ICP and percent 
change in either extracellular brain glutamate or glutamine (data not shown). 
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Figure 5. Extracellular brain concentrations of (A) glutamate and (B) glutamine following induction of ALF at T = 
0 (**P < 0.01, *P < 0.05 versus SHAM; 
†††
P < 0.01, 
†
P < 0.05, ALF versus MARS; 2-way ANOVA). 
 
Figure 6. LDH activity (% baseline) in frontal cortex following induction of ALF at T = 0 (*P < 0.05 
versus SHAM; 1-way ANOVA). 
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Lactate Dehydrogenase Activity in Brain. 
An increase in LDH activity was found in the frontal cortex in pigs with ALF compared to sham pigs. This same increase 
was found following a 4-hour MARS treatment (Fig. 6). 
Oxygen Extraction. 
The calculated oxygen extraction showed no significant change in oxygen uptake across the brain in all 3 groups at T = 6 
hours (sham: 0.53 ± 0.03; ALF: 0.55 ± 0.02; ALF+MARS: 0.57 ± 0.03). 
Mitochondrial Enzyme Activity. 
No differences were found between the groups in the activity levels of mitochondrial electron transport chain complexes I 
or II/III (Fig. 7A,B). A significant increase in the activity of complex IV (cytochrome c oxidase) was found in brain tissue 
(frontal cortex) homogenates from pigs in both the ALF and ALF+MARS groups compared to sham animals (P < 0.05 
for both, Fig. 7C). This finding was reflected in the increased level of cytochrome c oxidase protein measured in the 
homogenate, which was likewise significantly increased in both test groups compared to the sham-operated control (P < 
0.05 for both, Fig. 7D). 
 
Figure 7. (A) Mitochondrial complex I activity relative to citrate synthase activity, expressed as the 
rotenone-sensitive rate; (B) complex II/III combined activity relative to citrate synthase activity, 
expressed as the antimycin A–sensitive rate; (C) complex IV activity assay relative to citrate synthase 
activity, expressed as the cyanide-sensitive rate; (D) concentration of complex IV in brain tissue 
homogenate (*P < 0.05 versus SHAM; 1-way ANOVA). 
DISCUSSION 
We previously demonstrated in pigs with ALF that a 4-hour albumin dialysis (MARS) treatment results in attenuation of 
increased ICP.
17
 We also observed that this reduction in ICP was independent of changes in the currently proposed 
pathophysiological mechanisms: arterial ammonia, cerebral blood flow, and inflammation. Hence, this experimental 
paradigm allows testing for alternative hypotheses. The results of this study reveal that the development of intracranial 
hypertension in ALF is associated with increased extracellular brain ammonia, lactate, and glutamate, with a significant 
correlation found between extracellular brain ammonia and lactate. The reduction in these metabolites in the MARS-
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treated animals in association with reduced ICP indicates the important role of these metabolites in the pathogenesis of 
intracranial hypertension in ALF. 
Our study provides novel data that indicate the importance of extracellular ammonia in the pathogenesis of increased ICP 
in ALF, including a correlation between percent change in extracellular brain ammonia and percent change in ICP. 
Previous studies have suggested that the rate of ammonia delivery to the brain correlates with the severity of intracranial 
hypertension in patients with ALF.
7
 Our study provides further insights into the relationship between arterial and 
extracellular brain ammonia. As early as 2 hours following ALF, pigs developed a significant increase in extracellular 
brain ammonia in the brain. From the beginning of the MARS treatment, at T = 2 hours, until T = 6 hours, extracellular 
brain ammonia rose 244% in the ALF pigs compared to 80% in the MARS-treated ALF pigs. This attenuation in the 
extracellular compartment of the brain in the MARS-treated animals (and no change in arterial ammonia
17
) depicts the 
importance of extracellular brain ammonia in the pathogenesis of intracranial hypertension in ALF. 
Changes in arterial and extracellular brain lactate occurred in a pattern similar to that of ammonia.
17
 An increase in 
extracellular brain and arterial lactate was observed in ALF pigs; however, only extracellular brain lactate was normalized 
following MARS treatment, as increased arterial lactate remained unaffected. This indicates that cerebral, and not arterial, 
lactate is likely to be more important in the pathophysiology of increased ICP in ALF. Our results are in keeping with 
similar observations in patients with ALF but argue against the suggestion that the increase in extracellular brain lactate is 
blood-borne rather than produced in the brain.
28
 Lactate is produced by the action of LDH, an enzyme in neurons and 
astrocytes that is implicated during anaerobic glycolysis/TCA cycle inhibition. Our data showing an increase in LDH 
activity in the pigs with ALF compared to sham-operated animals suggests that lactate production is occurring in the 
brain. An increase in extracellular brain lactate may result from an increase in anaerobic metabolism because of either 
cerebral hypoxia or inhibition of aerobic energy metabolism. The attenuation of the increased lactate:glucose and 
lactate:pyruvate ratios (with no change in extracellular brain glucose or pyruvate) in the ALF animals treated with MARS 
is the result of a reduction in extracellular brain lactate in the same animals. Interestingly, LDH activity was not 
attenuated in the MARS-treated pigs. The mechanism for this remains unclear; however, a decrease in extracellular 
lactate would result from increased removal or decreased utilization of lactate from the extracellular space. Lactate is not 
only an energy impairment marker but also an energy source for neurons.
29
 This would entail neurons removing lactate 
more efficiently in the MARS-treated pigs. 
To investigate whether the increase in lactate was a result of inhibition of aerobic energy metabolism, we measured the 
activity of mitochondrial enzyme complexes of the electron transport chain in the frontal cortex. We observed that 
complex IV activity was increased together with cytochrome oxidase in both the ALF- and ALF+MARS-treated animals. 
The activity of the other enzymes remained unchanged in all 3 groups. These data contrast with those of previous studies 
of cultured astrocytes exposed to 5 mM concentrations of ammonia, in which mitochondrial proteins (in particular, 
complex IV) were found to be reduced following long-term exposure.
30–32
 The maintenance of normal oxygen 
consumption further provides evidence that mitochondrial function is maintained in the brain during ALF. 
It is known that elevated ammonia concentrations inhibit α-ketoglutarate dehydrogenase6 and reduce energy availability.8, 
33
 A strong correlation between extracellular brain ammonia and extracellular brain lactate supports the hypothesis that 
ammonia may stimulate increased lactate. This increase in lactate may indicate a situation of energy deficit due to an 
imbalance between energy demand and supply. Brain detoxifies ammonia into glutamine by an energy-requiring process 
involving glutamine synthetase. Furthermore, ammonia and glutamine synthetase activity stimulate an increase in 
glutamate uptake into astrocytes.
9, 34
 This, in addition to glutamate-activated and/or ammonia-induced NMDA receptor 
activation, stimulates the ATP-required Na
+
-K
+
 ATPase. Therefore, ammonia may affect brain energy metabolism and 
increase extracellular brain lactate by increasing the demand for and impairing the supply of ATP. The correlation 
between extracellular brain ammonia and extracellular brain lactate along with a reduction of both in association with ICP 
attenuation in MARS-treated pigs further supports this hypothesis. 
This is the peer reviewed version of the following article: Rose C, Davies NA, Ytrebø LM, Sen S, Nedredal GI, Belanger M, Revhaug 
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An increase in extracellular brain glutamate has been consistently demonstrated in different animal models of ALF,
24, 35–38
 
which could be the result of decreased glutamate uptake or increased glutamate release.
39
 It has been recently 
demonstrated that an acute insult of ammonia leads to glutamate release from astrocytes.
40
 Accordingly, we observed an 
increase in extracellular brain glutamate in the ALF animals, which was normalized with MARS treatment. Glutamate 
uptake by high-affinity glutamate transporters
41
 found in astrocytes stimulates Na
+
/K
+
 ATPase, which increases aerobic 
glycolytic lactate production that is then taken up by neurons and used for oxidative phosphorylation.
29
 According to this 
hypothesis, a disproportionate amount of glycolysis may occur despite sufficient oxygen levels.
42
 The importance of 
extracellular brain glutamate in the pathogenesis of increased ICP is indicated by the observation that MARS-induced 
normalization of extracellular brain glutamate was associated with attenuation of the rise in ICP. The lack of correlation 
between extracellular brain glutamate and ICP in a study of patients with ALF may indicate that those patients were at a 
later stage of the disease.
28
 
Pigs with ALF showed an increase in extracellular brain glutamine that was unaffected by MARS treatment, supporting 
the view that extracellular brain glutamine is not likely to be important in increased ICP in ALF. These data are in 
contrast to those from a study of patients with ALF that showed extracellular brain glutamine was related to surges in 
ICP.
43
 This may be because we are studying the initiating mechanisms of intracranial hypertension in ALF. 
In summary, our results demonstrate that percent change in ICP is correlated with percent change in extracellular brain 
ammonia in pigs with ALF, which is associated with changes in extracellular lactate and glutamate but not glutamine. 
The attenuation of increased extracellular brain ammonia in the MARS-treated animals may reduce energy demand (by 
lowering extracellular brain glutamate) and increase supply, leading to attenuation of the increase in lactate. The 
observation that brain oxygen consumption and mitochondrial complex enzyme activity changed in parallel in both ALF- 
and MARS-treated animals supports this hypothesis. In conclusion, the results of our study indicate an important role for 
extracellular brain ammonia in the pathogenesis of intracranial hypertension in ALF, but how MARS reduces 
extracellular brain ammonia requires further investigation. 
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